A US biotech company faced a sudden surge in pharmacovigilance case volume after acquiring a new oncology product. Clinigen rapidly scaled operations, established a call center, and ensured regulatory compliance. Their swift staffing and process implementation led to a successful vendor transition and high-quality standards, with no safety findings during inspections.


Read this case study to learn how Clinigen ensured seamless case processing, regulatory compliance, and high-quality standards during the transition.